デフォルト表紙
市場調査レポート
商品コード
1420929

ヒト成長ホルモン市場:世界の産業分析、規模、シェア、成長、動向、および2023年~2031年予測

Human Growth Hormone Market (Route of Administration: Intravenous, Subcutaneous, Intramuscular, and Oral) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2031

出版日: | 発行: Transparency Market Research | ページ情報: 英文 170 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
ヒト成長ホルモン市場:世界の産業分析、規模、シェア、成長、動向、および2023年~2031年予測
出版日: 2023年12月14日
発行: Transparency Market Research
ページ情報: 英文 170 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ヒト成長ホルモン市場- レポートの範囲

世界のヒト成長ホルモン市場に関するTMRのレポートは、過去と現在の成長動向、および2023年から2031年の予測期間中に市場の指標の貴重な洞察を得る機会を研究しています。当レポートは、2023年を基準年、2031年を予測年とし、2017年から2031年の期間における世界市場の収益を提供します。また、2023年から2031年までの複合年間成長率(CAGR %)も提供します。

このレポートは広範な調査を経て作成されました。1次調査では、調査活動の大部分が行われ、アナリストが主要なオピニオンリーダー、業界リーダー、オピニオンメーカーにインタビューを実施しました。2次調査には、ヒト成長ホルモン市場を理解するために、主要企業の製品文献、年次報告書、プレスリリース、および関連文書の参照が含まれます。

市場スナップショット
2023年の市場価値 28億米ドル
2031年の市場価値 39億米ドル
CAGR 3.7%

このレポートは、世界のヒト成長ホルモン市場の競合情勢を詳しく掘り下げています。世界のヒト成長ホルモン市場で活動している主要企業が特定され、これらのそれぞれがさまざまな属性の観点からプロファイルされています。会社概要、財務状況、最近の動向、 SWOTは、このレポートで紹介されている世界のヒト成長ホルモン市場のプレーヤーの属性です。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー:世界市場

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
  • 世界市場の分析と予測、2023~2031年

第5章 重要な洞察

  • パイプライン分析
  • 主な合併と買収
  • COVID-19感染症のパンデミックが業界に与える影響

第6章 世界市場の分析と予測:投与経路別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測:投与経路別、2023-2031
    • 静脈内
    • 皮下
    • 筋肉内
    • 経口
  • 市場魅力度分析:投与経路別

第7章 世界市場の分析と予測:流通チャネル別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測:流通チャネル別、2023-2031
    • 病院薬局
    • オンライン薬局
    • 小売薬局
    • クリニック
  • 市場魅力度分析:流通チャネル別

第8章 世界市場の分析と予測:適応症別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測:適応症別、2023-2031
    • 成長ホルモン欠乏症
    • ターナー症候群
    • 特発性低身長
    • プラダーウィリ症候群
    • その他の適応症
  • 市場魅力度分析:適応症別

第9章 世界市場の分析と予測:地域別

  • 主な調査結果
  • 市場金額予測:地域別、2023-2031
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場魅力度分析:地域別

第10章 北米市場の分析と予測

第11章 欧州市場の分析と予測

第12章 アジア太平洋市場の分析と予測

第13章 ラテンアメリカ市場の分析と予測

第14章 中東およびアフリカ市場の分析と予測

第15章 競合情勢

  • 市場プレーヤー- 競争マトリックス(企業の階層および規模別)
  • 市場シェア分析:企業別(2022年)
  • 企業プロファイル
    • Merck KGaA
    • Eli Lilly and Company
    • Pfizer Inc
    • Novo Nordisk A/S
    • Ipsen SA
    • Roche Holdings, Inc
    • Anhui Anke Biotechnology(Group)Co., Ltd.
    • Biopartners GmbH
    • GeneScience Pharmaceuticals Co., Ltd.
    • Novartis AG
図表

List of Tables

  • Table 01: Global Human Growth Hormone Market Size (US$ Mn) Forecast, by Route of Administration, 2023-2031
  • Table 02: Global Human Growth Hormone Market Size (US$ Mn) Forecast, by Distribution Channel, 2023-2031
  • Table 03: Global Human Growth Hormone Market Size (US$ Mn) Forecast, by Indication, 2023-2031
  • Table 04: Global Human Growth Hormone Market Size (US$ Mn) Forecast, by Region, 2023-2031
  • Table 05: North America Human Growth Hormone Market Size (US$ Mn) Forecast, by Country, 2023-2031
  • Table 06: North America Human Growth Hormone Market Size (US$ Mn) Forecast, by Route of Administration, 2023-2031
  • Table 07: North America Human Growth Hormone Market Size (US$ Mn) Forecast, by Distribution Channel, 2023-2031
  • Table 08: North America Human Growth Hormone Market Size (US$ Mn) Forecast, by Indication, 2023-2031
  • Table 09: Europe Human Growth Hormone Market Size (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 10: Europe Human Growth Hormone Market Size (US$ Mn) Forecast, by Route of Administration, 2023-2031
  • Table 11: Europe Human Growth Hormone Market Size (US$ Mn) Forecast, by Distribution Channel, 2023-2031
  • Table 12: Europe Human Growth Hormone Market Size (US$ Mn) Forecast, by Indication, 2023-2031
  • Table 13: Asia Pacific Human Growth Hormone Market Size (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 14: Asia Pacific Human Growth Hormone Market Size (US$ Mn) Forecast, by Route of Administration, 2023-2031
  • Table 15: Asia Pacific Human Growth Hormone Market Size (US$ Mn) Forecast, by Distribution Channel, 2023-2031
  • Table 16: Asia Pacific Human Growth Hormone Market Size (US$ Mn) Forecast, by Indication, 2023-2031
  • Table 17: Latin America Human Growth Hormone Market Size (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 18: Latin America Human Growth Hormone Market Size (US$ Mn) Forecast, by Route of Administration, 2023-2031
  • Table 19: Latin America Human Growth Hormone Market Size (US$ Mn) Forecast, by Distribution Channel, 2023-2031
  • Table 20: Latin America Human Growth Hormone Market Size (US$ Mn) Forecast, by Indication, 2023-2031
  • Table 21: Middle East & Africa Human Growth Hormone Market Size (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 22: Middle East & Africa Human Growth Hormone Market Size (US$ Mn) Forecast, by Route of Administration, 2023-2031
  • Table 23: Middle East & Africa Human Growth Hormone Market Size (US$ Mn) Forecast, by Distribution Channel, 2023-2031
  • Table 24: Middle East & Africa Human Growth Hormone Market Size (US$ Mn) Forecast, by Indication, 2023-2031

List of Figures

  • Figure 01: Global Human Growth Hormone Market Size (US$ Mn) and Distribution (%), by Region, 2022 and 2031
  • Figure 02: Global Human Growth Hormone Market Revenue (US$ Mn), by Route of Administration, 2022
  • Figure 03: Global Human Growth Hormone Market Value Share, by Route of Administration, 2022
  • Figure 04: Global Human Growth Hormone Market Revenue (US$ Mn), by Distribution Channel, 2022
  • Figure 05: Global Human Growth Hormone Market Value Share, by Distribution Channel, 2022
  • Figure 06: Global Human Growth Hormone Market Revenue (US$ Mn), by Indication, 2022
  • Figure 07: Global Human Growth Hormone Market Value Share, by Indication, 2022
  • Figure 08: Global Human Growth Hormone Market Value Share, by Region, 2022
  • Figure 09: Global Human Growth Hormone Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 10: Global Human Growth Hormone Market Value Share Analysis, by Route of Administration, 2022 and 2031
  • Figure 11: Global Human Growth Hormone Market Attractiveness Analysis, by Route of Administration, 2023-2031
  • Figure 12: Global Human Growth Hormone Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 13: Global Human Growth Hormone Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 14: Global Human Growth Hormone Market Value Share Analysis, by Indication, 2022 and 2031
  • Figure 15: Global Human Growth Hormone Market Attractiveness Analysis, by Indication, 2023-2031
  • Figure 16: Global Human Growth Hormone Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 17: Global Human Growth Hormone Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 18: North America Human Growth Hormone Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2023-2031
  • Figure 19: North America Human Growth Hormone Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 20: North America Human Growth Hormone Market Value Share Analysis, by Country, 2023 and 2031
  • Figure 21: North America Human Growth Hormone Market Value Share Analysis, by Route of Administration, 2022 and 2031
  • Figure 22: North America Human Growth Hormone Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 23: North America Human Growth Hormone Market Value Share Analysis, by Indication, 2022 and 2031
  • Figure 24: North America Human Growth Hormone Market Attractiveness Analysis, by Route of Administration, 2023-2031
  • Figure 25: North America Human Growth Hormone Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 26:North America Human Growth Hormone Market Attractiveness Analysis, by Indication, 2023-2031
  • Figure 27: Europe Human Growth Hormone Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2023-2031
  • Figure 28: Europe Human Growth Hormone Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 29: Europe Human Growth Hormone Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 30: Europe Human Growth Hormone Market Value Share Analysis, by Route of Administration, 2022 and 2031
  • Figure 31: Europe Human Growth Hormone Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 32: Europe Human Growth Hormone Market Value Share Analysis, by Indication, 2022 and 2031
  • Figure 33: Europe Human Growth Hormone Market Attractiveness Analysis, by Route of Administration, 2023-2031
  • Figure 34: Europe Human Growth Hormone Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 35: Europe Human Growth Hormone Market Attractiveness Analysis, by Indication, 2023-2031
  • Figure 36: Asia Pacific Human Growth Hormone Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2023-2031
  • Figure 37: Asia Pacific Human Growth Hormone Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 38: Asia Pacific Human Growth Hormone Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 39: Asia Pacific Human Growth Hormone Market Value Share Analysis, by Route of Administration, 2022 and 2031
  • Figure 40: Asia Pacific Human Growth Hormone Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 41: Asia Pacific Human Growth Hormone Market Value Share Analysis, by Indication, 2022 and 2031
  • Figure 42: Asia Pacific Human Growth Hormone Market Attractiveness Analysis, by Route of Administration, 2023-2031
  • Figure 43: Asia Pacific Human Growth Hormone Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 44: Asia Pacific Human Growth Hormone Market Attractiveness Analysis, by Indication, 2023-2031
  • Figure 45: Latin America Human Growth Hormone Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2023-2031
  • Figure 46: Latin America Human Growth Hormone Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 47: Latin America Human Growth Hormone Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 48: Latin America Human Growth Hormone Market Value Share Analysis, by Route of Administration, 2022 and 2031
  • Figure 49: Latin America Human Growth Hormone Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 50: Latin America Human Growth Hormone Market Value Share Analysis, by Indication, 2022 and 2031
  • Figure 51: Latin America Human Growth Hormone Market Attractiveness Analysis, by Route of Administration, 2023-2031
  • Figure 52: Latin America Human Growth Hormone Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 53: Latin America Human Growth Hormone Market Attractiveness Analysis, by Indication, 2023-2031
  • Figure 54: Middle East & Africa Human Growth Hormone Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2023-2031
  • Figure 55: Middle East & Africa Human Growth Hormone Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 56: Middle East & Africa Human Growth Hormone Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 57: Middle East & Africa Human Growth Hormone Market Value Share Analysis, by Route of Administration, 2022 and 2031
  • Figure 58: Middle East & Africa Human Growth Hormone Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 59: Middle East & Africa Human Growth Hormone Market Value Share Analysis, by Indication, 2022 and 2031
  • Figure 60: Middle East & Africa Human Growth Hormone Market Attractiveness Analysis, by Route of Administration, 2023-2031
  • Figure 61: Middle East & Africa Human Growth Hormone Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 62: Middle East & Africa Human Growth Hormone Market Attractiveness Analysis, by Indication, 2023-2031
目次
Product Code: TMRGL16283

Human Growth Hormone Market - Scope of Report

TMR's report on the global human growth hormone market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global human growth hormone market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global human growth hormone market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the human growth hormone market.

Market Snapshot
Market Value in 2023US$ 2.8 Bn
Market Value in 2031US$ 3.9 Bn
CAGR3.7%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global human growth hormone market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global human growth hormone market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global human growth hormone market.

The report delves into the competitive landscape of the global human growth hormone market. Key players operating in the global human growth hormone market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global human growth hormone market profiled in this report.

Key Questions Answered in Global human growth hormone Market Report:

  • What is the sales/revenue generated by human growth hormone across all regions during the forecast period?
  • What are the opportunities in the global human growth hormone market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Human Growth Hormone Market - Research Objectives and Research Approach

The comprehensive report on the global human growth hormone market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global human growth hormone market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global human growth hormone market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Human Growth Hormone Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution/Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Human Growth Hormone Market Analysis and Forecast, 2023-2031

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Mergers & Acquisitions
  • 5.3. COVID-19 Pandemic Impact on Industry

6. Global Human Growth Hormone Market Analysis and Forecast, by Route of Administration

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Route of Administration, 2023-2031
    • 6.3.1. Intravenous
    • 6.3.2. Subcutaneous
    • 6.3.3. Intramuscular
    • 6.3.4. Oral
  • 6.4. Market Attractiveness Analysis, by Route of Administration

7. Global Human Growth Hormone Market Analysis and Forecast, by Distribution Channel

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Distribution Channel, 2023-2031
    • 7.3.1. Hospital Pharmacy
    • 7.3.2. Online Pharmacy
    • 7.3.3. Retail Pharmacy
    • 7.3.4. Clinics
  • 7.4. Market Attractiveness Analysis, by Distribution Channel

8. Global Human Growth Hormone Market Analysis and Forecast, by Indication

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Indication, 2023-2031
    • 8.3.1. Growth Hormone Deficiency
    • 8.3.2. Turner Syndrome
    • 8.3.3. Idiopathic Short Stature
    • 8.3.4. Prader-Willi Syndrome
    • 8.3.5. Other Indications
  • 8.4. Market Attractiveness Analysis, by Indication

9. Global Human Growth Hormone Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region, 2023-2031
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Human Growth Hormone Market Analysis and Forecast

  • 10.1. Introduction
  • 10.2. Key Findings
  • 10.3. Market Value Forecast, by Route of Administration, 2023-2031
    • 10.3.1. Intravenous
    • 10.3.2. Subcutaneous
    • 10.3.3. Intramuscular
    • 10.3.4. Oral
  • 10.4. Market Value Forecast, by Distribution Channel, 2023-2031
    • 10.4.1. Hospital Pharmacy
    • 10.4.2. Online Pharmacy
    • 10.4.3. Retail Pharmacy
    • 10.4.4. Clinics
  • 10.5. Market Value Forecast, by Indication, 2023-2031
    • 10.5.1. Growth Hormone Deficiency
    • 10.5.2. Turner Syndrome
    • 10.5.3. Idiopathic Short Stature
    • 10.5.4. Prader-Willi Syndrome
    • 10.5.5. Other Indications
  • 10.6. Market Value Forecast, by Country, 2023-2031
    • 10.6.1. U.S.
    • 10.6.2. Canada
  • 10.7. Market Attractiveness Analysis
    • 10.7.1. By Route of Administration
    • 10.7.2. By Distribution Channel
    • 10.7.3. By Indication
    • 10.7.4. By Country

11. Europe Human Growth Hormone Market Analysis and Forecast

  • 11.1. Introduction
  • 11.2. Key Findings
  • 11.3. Market Value Forecast, by Route of Administration, 2023-2031
    • 11.3.1. Intravenous
    • 11.3.2. Subcutaneous
    • 11.3.3. Intramuscular
    • 11.3.4. Oral
  • 11.4. Market Value Forecast, by Distribution Channel, 2023-2031
    • 11.4.1. Hospital Pharmacy
    • 11.4.2. Online Pharmacy
    • 11.4.3. Retail Pharmacy
    • 11.4.4. Clinics
  • 11.5. Market Value Forecast, by Indication, 2023-2031
    • 11.5.1. Growth Hormone Deficiency
    • 11.5.2. Turner Syndrome
    • 11.5.3. Idiopathic Short Stature
    • 11.5.4. Prader-Willi Syndrome
    • 11.5.5. Other Indications
  • 11.6. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 11.6.1. Germany
    • 11.6.2. U.K.
    • 11.6.3. France
    • 11.6.4. Italy
    • 11.6.5. Spain
    • 11.6.6. Rest of Europe
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Route of Administration
    • 11.7.2. By Distribution Channel
    • 11.7.3. By Indication
    • 11.7.4. By Country/Sub-region

12. Asia Pacific Human Growth Hormone Market Analysis and Forecast

  • 12.1. Introduction
  • 12.2. Key Findings
  • 12.3. Market Value Forecast, by Route of Administration, 2023-2031
    • 12.3.1. Intravenous
    • 12.3.2. Subcutaneous
    • 12.3.3. Intramuscular
    • 12.3.4. Oral
  • 12.4. Market Value Forecast, by Distribution Channel, 2023-2031
    • 12.4.1. Hospital Pharmacy
    • 12.4.2. Online Pharmacy
    • 12.4.3. Retail Pharmacy
    • 12.4.4. Clinics
  • 12.5. Market Value Forecast, by Indication, 2023-2031
    • 12.5.1. Growth Hormone Deficiency
    • 12.5.2. Turner Syndrome
    • 12.5.3. Idiopathic Short Stature
    • 12.5.4. Prader-Willi Syndrome
    • 12.5.5. Other Indications
  • 12.6. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 12.6.1. China
    • 12.6.2. Japan
    • 12.6.3. India
    • 12.6.4. Australia & New Zealand
    • 12.6.5. Rest of Asia Pacific
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Route of Administration
    • 12.7.2. By Distribution Channel
    • 12.7.3. By Indication
    • 12.7.4. By Country/Sub-region

13. Latin America Human Growth Hormone Market Analysis and Forecast

  • 13.1. Introduction
  • 13.2. Key Findings
  • 13.3. Market Value Forecast, by Route of Administration, 2023-2031
    • 13.3.1. Intravenous
    • 13.3.2. Subcutaneous
    • 13.3.3. Intramuscular
    • 13.3.4. Oral
  • 13.4. Market Value Forecast, by Distribution Channel, 2023-2031
    • 13.4.1. Hospital Pharmacy
    • 13.4.2. Online Pharmacy
    • 13.4.3. Retail Pharmacy
    • 13.4.4. Clinics
  • 13.5. Market Value Forecast, by Indication, 2023-2031
    • 13.5.1. Growth Hormone Deficiency
    • 13.5.2. Turner Syndrome
    • 13.5.3. Idiopathic Short Stature
    • 13.5.4. Prader-Willi Syndrome
    • 13.5.5. Other Indications
  • 13.6. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 13.6.1. Brazil
    • 13.6.2. Mexico
    • 13.6.3. Rest of Latin America
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Route of Administration
    • 13.7.2. By Distribution Channel
    • 13.7.3. By Indication
    • 13.7.4. By Country/Sub-region

14. Middle East & Africa Human Growth Hormone Market Analysis and Forecast

  • 14.1. Introduction
  • 14.2. Key Findings
  • 14.3. Market Value Forecast, by Route of Administration, 2023-2031
    • 14.3.1. Intravenous
    • 14.3.2. Subcutaneous
    • 14.3.3. Intramuscular
    • 14.3.4. Oral
  • 14.4. Market Value Forecast, by Distribution Channel, 2023-2031
    • 14.4.1. Hospital Pharmacy
    • 14.4.2. Online Pharmacy
    • 14.4.3. Retail Pharmacy
    • 14.4.4. Clinics
  • 14.5. Market Value Forecast, by Indication, 2023-2031
    • 14.5.1. Growth Hormone Deficiency
    • 14.5.2. Turner Syndrome
    • 14.5.3. Idiopathic Short Stature
    • 14.5.4. Prader-Willi Syndrome
    • 14.5.5. Other Indications
  • 14.6. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 14.6.1. GCC Countries
    • 14.6.2. South Africa
    • 14.6.3. Rest of Middle East & Africa
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Route of Administration
    • 14.7.2. By Distribution Channel
    • 14.7.3. By Indication
    • 14.7.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
  • 15.2. Market Share Analysis, by Company (2022)
  • 15.3. Company Profiles
    • 15.3.1. Merck KGaA
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Product Portfolio
      • 15.3.1.3. SWOT Analysis
      • 15.3.1.4. Financial Overview
      • 15.3.1.5. Strategic Overview
    • 15.3.2. Eli Lilly and Company
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Product Portfolio
      • 15.3.2.3. SWOT Analysis
      • 15.3.2.4. Financial Overview
      • 15.3.2.5. Strategic Overview
    • 15.3.3. Pfizer Inc
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Product Portfolio
      • 15.3.3.3. SWOT Analysis
      • 15.3.3.4. Financial Overview
      • 15.3.3.5. Strategic Overview
    • 15.3.4. Novo Nordisk A/S
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Product Portfolio
      • 15.3.4.3. SWOT Analysis
      • 15.3.4.4. Financial Overview
      • 15.3.4.5. Strategic Overview
    • 15.3.5. Ipsen SA
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Product Portfolio
      • 15.3.5.3. SWOT Analysis
      • 15.3.5.4. Financial Overview
      • 15.3.5.5. Strategic Overview
    • 15.3.6. Roche Holdings, Inc
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Product Portfolio
      • 15.3.6.3. SWOT Analysis
      • 15.3.6.4. Financial Overview
      • 15.3.6.5. Strategic Overview
    • 15.3.7. Anhui Anke Biotechnology (Group) Co., Ltd.
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Product Portfolio
      • 15.3.7.3. SWOT Analysis
      • 15.3.7.4. Financial Overview
      • 15.3.7.5. Strategic Overview
    • 15.3.8. Biopartners GmbH
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Product Portfolio
      • 15.3.8.3. SWOT Analysis
      • 15.3.8.4. Financial Overview
      • 15.3.8.5. Strategic Overview
    • 15.3.9. GeneScience Pharmaceuticals Co., Ltd.
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Product Portfolio
      • 15.3.9.3. SWOT Analysis
      • 15.3.9.4. Financial Overview
      • 15.3.9.5. Strategic Overview
    • 15.3.10. Novartis AG
      • 15.3.10.1. Company Overview
      • 15.3.10.2. Product Portfolio
      • 15.3.10.3. SWOT Analysis
      • 15.3.10.4. Financial Overview
      • 15.3.10.5. Strategic Overview